Mucus as a barrier to drug delivery - Understanding and mimicking the barrier properties

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 3, 2015, Pages 179-186

  Boegh, Marie ^a   Nielsen, Hanne Mørck ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; NANOPARTICLE; PEPTIDE; PROTEIN;

CELL CULTURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HUMAN; HYDROPHILICITY; IN VITRO STUDY; MUCUS; MUCUS SECRETION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; VISCOSITY; ANIMAL; BIOAVAILABILITY; BIOLOGICAL MODEL; DRUG DESIGN; METABOLISM;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MODELS, BIOLOGICAL; MUCINS; MUCUS; NANOPARTICLES; PEPTIDES; PROTEINS;

EID: 84922721000     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12342     Document Type: Review

References (50)

1. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov 2005;4:298-306.
2. Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2003;2:289-95.
3. Boegh M, Foged C, Mullertz A, Nielsen HM. Mucosal drug delivery: barriers, in vitro models and formulation strategies. J Drug Del Sci Tech 2013;23:383-91.
4. Li H, Yu Y, Faraji DS, Li B, Lee CY, Kang L. Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target 2013;21:611-29.
5. Shen L. Functional morphology of the gastrointestinal tract. In: Sasakawa C. (ed). Molecular Mechanisms of Bacterial Infection Via the Gut. Springer, Berlin Heidelberg, 2009;1-35.
6. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev 2009;61:75-85.
7. Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013;10:352-61.
8. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997;14:569-76.
9. Allen A. Gastrointestinal mucus. In: Schultz SG, Forte JG, Rauner BB (eds). Handbook of Physiology - A critical, Comprehensive Presentation of Physiological Knowledge and Concepts. Sec. 6 The gastrointestinal system. Am Physiol Soc 1989:359-82.
10. Round AN, McMaster TJ, Miles MJ, Corfield AP, Berry M. The isolated MUC5AC gene product from human ocular mucin displays intramolecular conformational heterogeneity. Glycobiology 2007;17:578-85.
11. Svensson O, Arnebrant T. Mucin layers and multilayers - physicochemical properties and applications. Curr Opin Colloid Interface Sci 2010;15:395-405.
12. Sigurdsson HH, Kirch J, Lehr CM. Mucus as a barrier to lipophilic drugs. Int J Pharm 2013;453:56-64.
13. Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 2012;64:557-70.
14. Boegh M, Baldursdottir SG, Mullertz A, Nielsen HM. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption. Eur J Pharm Biopharm 2014;87:227-35.
15. Kirch J, Schneider A, Abou B, Hopf A, Schaefer UF, Schneider M et al. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus. Proc Natl Acad Sci USA 2012;109:18355-60.
16. Lai SK, Wang YY, Hida K, Cone R, Hanes J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA 2010;107:598-603.
17. Ensign LM, Henning A, Schneider CS, Maisel K, Wang YY, Porosoff MD et al. Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Mol Pharm 2013;10:2176-82.
18. Sellers LA, Allen A, Morris ER, Murphy SR. Rheological studies on pig gastrointestinal mucous secretions. Biochem Soc Trans 1983;11:763-4.
19. Celli JP, Turner BS, Afdhal NH, Ewoldt RH, McKinley GH, Bansil R et al. Rheology of gastric mucin exhibits a pH-dependent sol-gel transition. Biomacromolecules 2007;8:1580-6.
20. Cao X, Bansil R, Bhaskar KR, Turner BS, LaMont JT, Niu N et al. pH-dependent conformational change of gastric mucin leads to sol-gel transition. Biophys J 1999;76:1250-8.
21. Hong Z, Chasan B, Bansil R, Turner BS, Bhaskar KR, Afdhal NH. Atomic force microscopy reveals aggregation of gastric mucin at low pH. Biomacromolecules 2005;6:3458-66.
22. Wang YY, Lai SK, Ensign LM, Zhong W, Cone R, Hanes J. The microstructure and bulk rheology of human cervicovaginal mucus are remarkably resistant to changes in pH. Biomacromolecules 2013;14:4429-35.
23. Lieleg O, Ribbeck K. Biological hydrogels as selective diffusion barriers. Trends Cell Biol 2011;21:543-51.
24. Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001;280:922-9.
25. Varum FJ, Veiga F, Sousa JS, Basit AW. Mucus thickness in the gastrointestinal tract of laboratory animals. J Pharm Pharmacol 2012;64:218-27.
26. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009;61:158-71.
27. Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol Biosci 2010;10:1473-83.
28. Friedl H, Dunnhaupt S, Hintzen F, Waldner C, Parikh S, Pearson JP et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci 2013;102:4406-13.
29. Li LD, Crouzier T, Sarkar A, Dunphy L, Han J, Ribbeck K. Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier. Biophys J 2013;105:1357-65.
30. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 1995;16:351-80.
31. Groo AC, Saulnier P, Gimel JC, Gravier J, Ailhas C, Benoit JP et al. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomedicine 2013;8:4291-302.
32. Kocevar-Nared J, Kristl J, Smid-Korbar J. Comparative rheological investigation of crude gastric mucin and natural gastric mucus. Biomaterials 1997;18:677-81.
33. Burruano BT, Schnaare RL, Malamud D. Synthetic cervical mucus formulation. Contraception 2002;66:137-40.
34. Larhed AW, Artursson P, Bjork E. The influence of intestinal mucus components on the diffusion of drugs. Pharm Res 1998;15:66-71.
35. Antunes F, Andrade F, Araujo F, Ferreira D, Sarmento B. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 2013;83:427-35.
36. Navabi N, McGuckin MA, Linden SK. Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation. PLoS One 2013;8:e68761.
37. Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 1976;12:180-91.
38. Grainger CI, Greenwell LL, Lockley DJ, Martin GP, Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res 2006;23:1482-90.
39. Teubl BJ, Absenger M, Frohlich E, Leitinger G, Zimmer A, Roblegg E. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model. Eur J Pharm Biopharm 2013;84:386-93.
40. Groo AC, Mircheva K, Bejaud J, Ailhas C, Panaiotov I, Saulnier P et al. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules. Pharm Res 2014;31:1753-65.
41. Forier K, Messiaen AS, Raemdonck K, Deschout H, Rejman J, De BF et al. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. Nanomedicine 2013;8:935-49.
42. Schuster BS, Suk JS, Woodworth GF, Hanes J. Nanoparticle diffusion in respiratory mucus from humans without lung disease. Biomaterials 2013;34:3439-46.
43. Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl 2008;47:9726-9.
44. Ensign LM, Schneider C, Suk JS, Cone R, Hanes J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater 2012;24:3887-94.
45. Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS et al. Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci 1993;106:771-83.
46. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J 2001;81:1930-7.
47. Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm 2012;81:514-23.
48. Bernkop-Schnürch A, Fragner R. Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm Pharmacol Commun 1996;2:361-3.
49. Desai MA, Mutlu M, Vadgama P. A study of macromolecular diffusion through native porcine mucus. Experientia 1992;48:22-6.
50. Flemstrom G, Hallgren A, Nylander O, Engstrand L, Wilander E, Allen A. Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo. Am J Physiol 1999;277:375-82.